China Medipharm Insights - Issue 63


Regular Price: USD 1,000.00

Special Price USD 700.00

30% OFF

* Required Fields

Regular Price: USD 1,000.00

Special Price USD 700.00


Be the first to review this product

Table of Contents

China Medipharm Insights - Issue 63, China Medipharm Insights – Issue 63/August 2001Market AnalysisChinese Pharmaceutical Industry Posts 12.8 Percent Growth in Year 2000Company ProfilesNorth China Pharma Group Wins Largest Bid of Drug Procurement in BeijingNorth China Pharma Expands Hepatitis B Vaccine ProductionShijiazhuang Pharma Group Ouyi Branch EstablishedEssex Biotech Raises Funds in Hong Kong Stock ExchangeLukang’s Pediatric Drugs Cater to Market DemandGuangji Pharma Switches Investment ProjectZhongyuanwei Biopharma Raises Funds in Hong Kong Stock ExchangeExportation in Biocause Pharma ProspersLunan Pharma Benefits from High Tech999 Pharma Opens Chain Drug Store in YunnanShenzhen TCM & Plant Drug Research Center EstablishedGuilin Nanyao Pharma EstablishedShanghai Eastbest Biopharma Plans Center on New Drug R&DChina Medicines Group Corporation Opens Branch in Xi’anBeijing Wuzhou Medicines Co. EstablishedDrug ConsumptionHospital Drug Consumption Analysis for 10 Major Chinese Cities in 2000Product NewsAnti-cancer Kang Lai Te Starts Phase I Clinical Trials in U.S.Kytril Re-launched by RocheDuobeisi Launched by Xi’an RejoyCefetamet Piroxil Launched by Northeast PharmaLukang Qianle’an Passes Expert EvaluationEnboke Cream Cleared for MarketingAzithromycin Marketed by Shunfeng PharmaHuman Albumin Produced by Transgene TechnologyMai’an Capsules Marketed by Xinhua PharmaAnti-cancer Gene Vaccine Developed by Shanghai Second Medical UniversityKaipufei Launched by Hainan QinshengMarket analysisMarket Analysis of Calcium Products in First Quarter 2001News in Brief Pharmaceutical Industry Keeps Booming in First Quarter 2001Planned Vaccination Saves Millions in Medical ExpensesHealthcare Spending Drops in HebeiShanghai Strengthens Adverse Drug Reaction Surveillance SystemChina Issues Strategic Plans for Pharmaceutical Industry Development From 2001-2005Hospitals Open Retail Drug Stores in ChengduChengdu Retail Drug Stores Practice Unified Drug Procurement Through BiddingGuiyang Hospitals Adopt Unified Drug Procurement through BiddingDrug Prices in Hubei Cut 20 Percent Through Unified Drug Procurement Health InsuranceBasic Health Insurance to Cover Four Million Employees in SichuanMore People Buy Health Insurance in HangzhouHainan Adopts New Health Insurance PoliciesFujian Launches New Commercial Health Insurance PolicyGuizhou Sets Price Ceilings for Basic Health Insurance Drugs

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.